Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
sure would be nice to see the 25mg cbd drink for sale. and is it still going to be under the gnbt brand. gnbt from what I have seen has been doing a great job at keeping their investors updated on things. but it has been some time now since I have seen anything about the 25mg drink that they had a deal with pura and kaly for.
nothing about when any of these products could be ready for market. nothing about the financials. nothing about getting the ce removed. nothing about the mobile units. nothing about any other company being interested in their technology even thou they claim how superior it is. yet we have other companies putting pr's every week about making deals. why is it kaly is not making any deals with any companies out side of nouv pura and usmj that are all in bed together.
wow. kaly puts out news and the best thing you have to say is rkrk is never happy. guess you are like most of the investors with the news today. nothing to talk about and kaly is down. the only thing I pulled from it was they made me feel like I was correct all along about the gum and gummies. put out a pr months ago that they had an order for their gum and it would also be on the usmj web site. today they only mentioned usmj. was I correct there was no one else interested in their product except for usmj.
hard to believe no one posted the news this morning.
Kali Extracts Presents Cannabis Extract Biopharmaceutical Strategy Targeting $170 In Million Pharmaceutical Market Opportunity
Dallas, TX -- April 17, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published a presentation elaborating on the company’s overall strategy to discover, develop and commercialize novel therapeutics from its proprietary cannabinoid product platform. KALY owns and operates a patented cannabis extraction process. Following four years of research and development, the company recently executed a strategy to bring the resulting intellectual property (IP) into a public company as part of a plan to capitalize its next stage of development. KALY is that public company platform. In conjunction with that plan, the company has recently disclosed four of its leading research and development initiatives targeting four specific health issues:
1.Chronic Obstructive Pulmonary Disease (COPD) - The market for COPD treatment is anticipated to reach $14 billion by 2025;
2.Type 2 Diabetes - The market for Type 2 Diabetes is expected to be a $64 billion market by 2026;
3.Cancer Pain Management - The overall pain management treatment market is anticipated to reach $83 billion by 2024, and
4.Epilepsy - The market for epilepsy treatment is anticipated to reach $9 billion by 2022.
The presentation below and incorporated into the company’s website offers further detail on the company’s progress to date and plans moving forward to commercialize cannabis therapies.
Patented Cannabis Extracts Targeting $170 In Million Pharmaceutical Treatments
In the fourth quarter of last year, 2018, KALY acquired NCM Biotech (NCMB). NCMB is biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from a proprietary cannabinoid product platform in a broad range of disease areas. In four years of operations, the company has established a leading position in the development of plant-derived cannabinoid therapeutics through a proven drug discovery and patented development process. The resulting intellectual property portfolio and the established regulatory and manufacturing expertise have created a significant opportunity. KALY, through its subsidiary, NCMB has a deep pipeline of additional cannabinoid product candidates including four distinct compounds. KALY has completed the first stage of clinical development and testing for a Chronic Obstructive Pulmonary Disease (COPD) therapy and is currently conducting phase one development and trials for compounds targeting Cancer Pain Management, Type 2 Diabetes and Epilepsy.
$170 Million Cannabis Therapeutics Market Opportunity
1.Chronic Obstructive Pulmonary Disease (COPD) - The market for COPD treatment is anticipated to reach $14 billion by 2025;
2.Type 2 Diabetes - The market for Type 2 Diabetes is expected to be a $64 billion market by 2026;
3.Cancer Pain Management - The overall pain management treatment market is anticipated to reach $83 billion by 2024, and
4.Epilepsy - The market for epilepsy treatment is anticipated to reach $9 billion by 2022.
Cannabis Research Methodology
KALY, through its subsidiary NCMB focuses on the use of specific cannabis extracts alone, and also along with using a proprietary process which combines molecules of already proven therapeutic utility to combat a variety of clinical disorders. In recognition of the need to standardize candidate products and to determine mechanisms for action with scientific credibility, KALY has established collaborations with other companies and with universities to enhance understanding and provide scientific support to the introduction of novel cannabis extract formulations for the consumer marketplace.
KALY has already published its COPD research and initiated a second stage of research and development. Research reports on the first phase of development for KALY’s cannabis compounds for Type 2 Diabetes, Cancer Pain Management and Epilepsy are expected to be published later this year.
To accelerate development, KALY is developing key partners with an emphasis on establishing joint ventures with existing biopharmaceutical companies. The company has a $3.5 million development plan for its next stage of development and management is working diligently to fund that development plan through the capital structure of partner companies.
Beyond The Initial Four Therapies
Beyond the four specific cannabis therapies currently in various stages of research and development, KALY has a number of additional target therapies in its research pipeline. KALY’s proprietary extracts have been evaluated in a genomic study where the extracts have exhibited remarkable activity in gene arrays by up or down regulating individual genes by as much as 200 fold. Genes appearing especially sensitive to the introduction of KALY’s cannabis extracts were associated with inflammation, healing and cancer inhibition. The results of the genomic studies have served to initiate planning for a host of additional therapies that can be developed from KALY’s proprietary cannabis extracts.
$1 Million 2019 Revenue Target From Parallel Revenue Strategy
KALY is not relying on its biopharmaceutical development strategy alone to insure the company’s long-term success. With the popularity of cannabis extracts for infusion into various consumer products, KALY’s patented extraction process offers arguably the highest quality extract to the infusion market. Drawing on KALY’s patented cannabis extraction expertise, Puration’s (USOTC: PURA) EVERx CBD Sports Water is already the leading CBD infused beverage for the sports nutrition market. KALY has also introduced its own CBD confections line, Hemp4mula with CBD infused gum already on the market and gummies on the way. Hemp4mula is expected to be available on the Ecommerce site USMJ.com hosted by North American Cannabis Holdings, Inc. (USOTC: USMJ) (aka USMJ). KALY has also entered into a partnership with Nouveau (USOTC: NOUV), a cannabis cultivation company, with plans to develop a proprietary cannabis cultivar that can further enhance the quality of KALY’s extracts. KALY’s consumer revenue strategy offers a business line that can stand alone, but one that also provides KALY with the long-term staying power to take the necessary time to bring its cannabis extract biopharmaceutical products to market. Currently, KALY management anticipates that its $1 million 2019 revenue goal for its parallel consumersmarket strategy is well within reach
now that is a big change on how you post. before it was this is going to explode. this will close above .02 tomorrow. guess if you are wrong change the way you post. no sees me posting to others telling them to buy or sell. I just post what I think is going to happen. just like yesterday when I said I think it will go down more if we don't get anything out of kaly and it did. you said it was going to explode. did it? no you said it would close above .02 today. did it? no for the ones here that are long I hope it does explode. if it does I own enough shares that my kids and grand kids will never want for anything. but I still wont lie to others to make things look better then they are and try and get them to buy. I have a cost of .0012 so I can hold out. don't like to give up my gains but will get out with a nice profit no matter what.
so hard to believe any one here does not know where the otc site is after all the talk about the ce and kaly needs to file the updates to get rid of the ce. here is the link to the otc web site.
https://www.otcmarkets.com/stock/KALY/disclosure
and you will never see me lie about anything. I post what I feel and that is it.
is kaly the first company to come up with a new reason not to file financials. reread this from their late filing notice on why they did not file.
Reason for Delay in Posting Financial Report: State below in reasonable detail why the Yearly Report could not be filed within the prescribed time period.
Financials are not ready to file as the Company is waiting on the review from OTC on previous filings to ensure compliance.
so does this mean that if the otc does not except kaly's other filings that they will not file the filings we have been waiting for. just like little kids if you don't give me what I want I am not going to give this to you. the heck with the share holders. if fins where that good they would not care what the otc does. they would want us to see it. so I would have to believe they are not that good and don't want to put it out after trying to make us believe they are good. keep that carrot dangling in front of the believers so they will hold or buy more. sooner or later that carrot will wilt. looks like the past couple days that is what has happened. the carrot is wilting and is loosing it's attracting.
and here we go blame the shorts and the mm's. would hate to say some are selling do to the fact kaly has not come thru again. claim fins will be out on the 15th and nothing. it is simple. people do not buy and hold a stock when a company does not follow thru and leaves their investors hanging in the dark.
hmmmmm. who was it that posted yesterday that we would break .02 today. just goes to show how much knowledge they really have. unless we see some good news out of kaly soon this will drop more. hope they have something to help hold on to some of their gains in the pps. good luck to all.
that makes no sence. you say kaly cant post financials until the ce is removed then you say you believe they will post financials after the bell. missing what you are trying to say.
the past has nothing to do with anything. kaly has been updating with the otc and put out a notice of late filing stating the financials would be out on the 15th. if they do not follow thru it will just be more misleading bull crap and show they do not care about becoming current with the otc.
5 hole trades in the last 5 minutes of trading today and less then 40 thousand shares. is that a good sign of what is coming. I don't think so. volume and pps speak a lot and this is not saying much at all.
have to agree. with the hit we took Friday have to believe the same will happen Monday. Friday showed no sign of going up. it closed red with a big dip. so the only sign was down.
I hope you are correct. nothing would please me more then to be wrong on all of these. would love to see them take off and never look back. good luck to you and all.
feel sorry for the ones that bought around the .02 level. hope you did not buy because of the ones claiming it was about to explode. looks like it imploded. kaly said they had news before the financials and all we got was the gum will be on the usmj web site now that they caught up. caught up with what. another play on words. mentioned again about a contract with a distributor but still no name of the distributor. if they are caught up with this so called distributor then where can we buy the gum and the gummies. all I know is a few made themselves look bad claiming it was going to explode and how the new mm's where for big stocks and kaly was ready to take off. now all they want to do is blame the mm's and people having stop losses. the big truth is if there where enough buyers it would not matter if people had stop losses in place or not. the buying would of kept the pps going up. the past couple days the mm's tried to keep the pps. oh well all good things come to an end.
will we ever see any filings on nouv that shibley claimed he was going to take care of since he took control of nouv. has any of the 100 acres been planted yet? who are the new distributors that pura said they signed on at the Arnold show. how do we know what to believe when they do not follow thru.
have we heard anything about nouv planting a single seed yet. I want to believe in nouv and pura but they make it hard. just like shibley coming out months ago and stating that since he is taking control of nouv we will start to see filings for nouv to bring them current and get the dividends out. so far there has not been one single filing with the otc. how cam we believe in a company when they do not follow thru and not keep us updated on why.
nothing would make me happier then to see it go up. just sad how some get so upset when you post your thoughts on things unless it is all positive. and the sad fact is that if pura was to fill their investors in better we would not be going back and forth here. will see what tomorrow brings.
fact usmj out of stock.
fact pura announced a couple months ago the new bottles.
fact a poster on this board finally got his order and it was in the old bottles.
fact pura said they had a new distributor but will not put out the company name.
so lets see. pura has a new bottle but the company they picked is unable to keep up with a supply of empty bottles. possible.
kaly is unable to supply the cbd to keep up with bottling. possible.
the bottler pura picked out is unable to keep up with putting water in a bottle. possible.
fact pura put out a pr about acquiring a bottling plant and usmj is out of stock. could pura be on a sour note with the current bottler. possible.
fact would it make things easier for the investors if pura was forth coming and give real details so the investors would know what is going on. for sure.
should we listen to someone that has been on this board for less then a year and only post on the pura and kaly board. heck no.
would I bet that this person is an insider or paid to post. heck ya. at this time I think it would be a better bet then pura.
ooooops. now see what you started. starting to question things because you could not keep your mouth shut. good job buddy.
and I guess we should listen to someone like you. only been on ihub since june 2018 and all your post are on pura and kaly. getting paid or insider. or did you just start investing and think you know it all. my bet insider or getting paid to post.
like that makes a lot of sense. they had the old bottles all along and made their customers wait for their order because they did not want to use them. then a month later they decided to use them. I wont even remove your post for personal attack because I want others to see your answer. and far from being stressed. I am riding all free shares at this time. and I have no problem telling the bad as well as the good. you only want to see positive post. keep wearing those rose colored glasses.
someone does not like the truth. if you had an explanation you would say something instead of attack. guess you think I am wright and don't want others to think about it.
I am very happy to see the pps going up and I hope it continues. was in the hospital while this happened and missed it. but I also have a concern. a new company is in talks with usmj to put their cbd products on the usmj web site and yet we have no products from kaly on there. where is the gum and gummies. we need products out there to generate revenue. and I hope we see news on the other research out early tomorrow morning to counter act clay. good luck to all and may we go way above 2 tomorrow.
I don't know about the rest of you but I see a big problem with this picture. think about how long ago pura announced the new bottles. usmj out of stock. new distributors and here you are months later and your shipment is in the old bottles from what I can see. am I wrong? good luck to all.
Kali-Extracts Confirms 4th Cannabis Extract Pharmaceutical Research Project Adding To Research Targeting $160 Million Market
Print
Kali-Extracts Confirms 4th Cannabis Extract Pharmaceutical Research Project Adding To Research Targeting $160 Million Market
Dallas, Tx -- April 5, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed plans to reveal a fourth research and development initiative for a treatment of a heath issue with a cannabis extract derived from the company’s patented cannabis extraction process. The company currently has ongoing cannabis extract research and development targeting four specific health issues, COPD, Type 2 Diabetes, Cancer Pain Management and one additional health issue KALY plans to announce next week leading up to an online presentation with more detail on each of the treatment developments later this month. The market for Type 2 Diabetes is expected to be a $64 billion market by 2026. The market for COPD treatment is anticipated to reach $14 billion by 2025. The overall pain management treatment market is anticipated to reach $83 billion by 2024.
Beyond the four specific cannabis therapies currently in various stages of research and development, KALY has a number of additional target therapies in its research pipeline.
In addition to its pharmaceutical developments, KALY is generating revenue from is patented cannabis extraction process delivering proprietary extracts for infusion into non-pharmaceutical commercial products. KALY announced last week finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion. KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (USOTC: PURA) (“PURA”) leading EVERx CBD Sports Water. KALY has also recently announced plans to provide commercial extraction for Nouveau, Inc. (USOTC: NOUV) (“NOUV”) in conjunction with NOUV’s recently announced 100-acre hemp farm.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The first revenue generating contracts signed in December of 2018 will be reflected in the company’s upcoming annual report.
more and more places in myrtle beach starting to carry cbd products. wish kaly would get their products out.
the big question should be why are they out of stock. is it the bottler kaly does not have the cbd to add or what. why no update on the new distributor they claimed they signed on at the Arnold show and others that would be added. this has been the reason the hole time in my opinion that they are unable to hold any gains in the pps. they need to keep the investors better informed and build confidence so people will hold or even add more.
an update on the gum and gummies this afternoon could push this above 2. we need something solid to keep it going. glad to see the pps up and hope it continues for all. good luck to all.
I own a very small position in gnbt but hold a large position in kaly. but the best way to loose money is to invest in hopes and dreams. and yes I saw the news this morning on the stores. so think about if the deal is still on with gnbt what would have this mornings news done for both companies if the pr from kaly this morning stated that the new drink is for gnbt and will be on the shelfs of their new stores.
I have been invested in 100's of pinky stocks. not one of them ever mention the bad. they only talk about the good as in completed or forward looking. just like kaly how long ago was it they claimed they had orders for the gum and gummies and they did not mention who ordered the products. since then not a single word about the products. do you believe that they even produced the gum and gummies. with this family of companies you have to question everything as they do not fill you in as an investor. they do not answer the phone and they do not answer emails. if they where more forthcoming and had investor confidence you would see a lot more interest in the stock especially with todays news. the low volume shows lack of confidence. good luck to all.
because if you look at the other pr's they mention gnbt. now that the drink is almost ready they don't mention gnbt. been in enough small cap stocks and have learned to question things. gnbt has more funds and contacts to help promote the drink and get it in more stores then pura.
glad to do the 25mg drink is finally ready and should be out within 30 days. the only thing I did not like is nothing about the drink being for gnbt. is the deal still on with them.
I remember a pr kaly was in talks with alkame to put there equipment inside alkame and maybe plant hemp next door but we never heard anything after that.
how do you know kaly is operating out of alkame facility.
they all take bottles homes to fill with water out of the kitchen sink. brink them back and use an eye dropper to add cbd. put a postage stamp on it and stick it in the mail box.
wonder if it is true they have a new distributor with others to come. think they will ever share info with the investors. makes you wonder if it is true.
it is not a matter of meeting certain dates. what would you think if they put out a pr stating they had a distributor that has put in an order for the copd product. wouldn't that be hard to believe since we know there is no product at this time. so now look back how long ago it was they put out two separate pr's one for an order for the gummies and another one for the gum. so where can we find these items. I am sure they would want you to know where we could get them to help with sales. makes no sense not to let people know where to buy their product. then for how long have they been saying the 25mg drink will be on shelfs soon. then you get from pura they are still working on producing it. there is no explanation except there are no products at this time when kaly tries to make it sound like there are.
so you have done your due diligence and gone to see them. well fill use in. I guess 99% of investors go to the companies to check it out. that news to me. but since you are trying to back the company up we know you went there and if you didn't you have nothing invested here. or did you invest without doing the due diligence. please fill me in old wise one.
and so how does that look to any potential investor. hey guys if you want any info on this company spend the time and money to go see them to find out what you want to know as the company does not update the investors. and you know what their all going to believe what someone post to what they found when they went there in person. ok I'm going to go. be right back. ok I am back. they are selling 10 dollars of everx ever month. 5 million in gummies and 7 million in gum. now you should remortgage your tomorrow and put it all in kaly and pura because of what I found. it does not have to come from the company my word is good enough. that is how things work as far as you are concerned. what great advice. and I think most trash talk the company and I don't blame them as the company is not giving the investors the info they should get for having their money invested here and not even being shown the respect to keep them updated. sounds like all you want to see is positive post here.